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Recruitment of leukocytes circulating in our blood to the sites of infection or tissue damage is the key phenomenon in the acute inflammatory response(s). Among 
the leukocytes, neutrophils are primarily recruited into the areas of acute inflammation. When neutrophils interact with activated endothelium of the blood vessels, 
they become migratory and cross the endothelial layer of the blood vessel wall in a process called as leukocyte extravasation. Identifying and understanding the 
gene regulation of this extravasation phenomenon is one of the key objective of biomedical research aimed at ameliorating or alleviating the symptoms of various 
diseases, such as rheumatoid arthritis, asthma, anaphylaxis, atherosclerosis, ulcerative colitis etc., that are exacerbated by inappropriate inflammatory stimuli. 
Here, we decipher and discuss the key genes implicated in the leukocyte transmigration using the acute inflammation model called as the Dextran Sulphate Sodium 
(DSS) induced Colitis in mice as a classic paradigm. 
 






Arrays of steps are involved in leukocyte extravasation that occurs during the 
acute inflammatory response(s) [1, 2]. The neutrophils present in the 
bloodstream first loosely adhere to the endothelium through carbohydrate-
based ligands to cause sampling of the local micro-environment for signs of 
inflammation. Activated endothelial cells produce both soluble and surface-
bound molecules that trigger tight, integrin-mediated adhesion between the 
neutrophil and the endothelium. Neutrophils depart the flowing blood stream 
by first tethering and then rolling on the inflamed endothelial coating of the 
blood vessels. This occurs primarily in post-capilary and collecting venules in 
the systemic circulation. Under favourable environment, firmly adherent 
neutrophils then transmigrate across the endothelium. In vitro studies [3] have 
shown that the transmigration is a rapid process which is being completed in 
less than 2 minutes (Figure 1). Each step of neutrophil emigration has been 
associated with specific cell adhesion molecules (CAMs) and CAM activators 
and chemo-attractants [4, 5]. The neutrophil-endothelial cell interactions are 
initiated by interacting sets of CAMs and chemoattractant/activator molecules 
to form an “adhesion cascade.” The initial phase of inflammation, a transient 
slowing of neutrophils in postcapillary venules, is mediated by selectins. 
Subsequently, firm adhesion of neutrophils to the vessel wall occurs via 
interaction of the CD11/CD18integrins to endothelial ligands such as 
intercellular adhesion molecule-1 (ICAM-1) [6]. This binding requires 
activation of CD11/CD18 by exposure of the neutrophil to a variety of 
activating/chemoattractant molecules, such as platelet activating factor (PAF) 
or interleukin-8 (IL-8). The transmigration into tissues occurs, a process that 
requires both a chemotactic stimulus by chemokines and engagement of 
platelet endothelial cell adhesion molecule-1(PECAM-1) (Figure 2)  [5]. 
Several approaches have been used to probe the role of CAMs in vivo. These 
include the use of blocking antibodies, chimeric selectin-immunoglobulin 
proteins, Sialyl Lewis oligosaccharides and peptides, along with the study of 
humans and animals with genetically determined adhesion deficiencies.  These 
studies demonstrate that CAM blockade can effectively inhibit inflammation 
[6, 7]. Here, we specifically focus on the acute inflammation induced by 
Dextran Sulphate Sodium (DSS) using high throughput microarray data 
obtained from Gene Expression Omnibus (GEO) and discuss how the precise 
interaction as well as coordination of CAMs and the chemokines facilitate the 
neutrophil extravasation and transmigration during acute inflammation. 
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Figure 1: The Key Cellular Events Implicated in the Neutrophil Extravasation 
Model. The selectins, chemokines and integrins coordinate in capturing a 
circulating neutrophil to the vessel wall at the specific sites. This process 
usually takes within few milliseconds to seconds during the acute inflammatory 
process(s) triggered by invading microbes such as gram negative bacteria.   
Further neutrophil exposure to the apical endothelial chemokines causes the 
chemotaxis and triggers their potential to undergo transendothelial migration 
within minutes and more importantly without disrupting the integrity of the 
endothelial barrier surrounding the blood vessels. 
 
 
Figure 2: Molecular and Cellular Events in Neutrophil Transmigration during 
Acute Inflammation. During the‘resting-state’, the junction between 
endothelial cells lining the blood vessels is closed, and this integrity is 
mediated by homotypic binding of VE-cadherin, PECAM-1 and JAM 
molecules. The VE-cadherin is linked to the cytoskeleton via β catenin, and 
this association is required for its adhesive activity. As it proceeds through the 
multi-step adhesion cascade, a neutrophil might trigger the dissociation of the 
VE-cadherin-β-catenin complex by degradation of the β-catenin and 
redistribution and/or internalization of the VE-cadherin. During 
transendothelial migration, the homophilic interactions (JAM-JAM and 
PECAM-1-PECAM-1) between opposing endothelial cells might be disrupted 
by the neutrophil, which would result in loosening of the junction. Engagement 
of PECAM-1 might provide a scaffold to ‘walk’ the cell through the junction 
via haptotactic migration. 
 
Material and Methodology: 
Meta-Analysis of High-Throughput Genomics Data for deciphering Genes 
Implicated in the Leukocyte Transmigration in Acute DSS Colitis in Mice: 
The raw Affymetrix CEL files downloaded from the Gene Expression Omnibus 
(GSE22307) were normalized with RMA algorithm and subjected to a very 
stringent Statistical Analysis using One Way Analysis of Variance (ANOVA), 
followed by Tukey Honestly Significant Difference (HSD) Post-Hoc Test and 
Multiple Testing Correction (MTC) by applying the Benjamini-Hochberg False 
Discovery Rate (FDR) (p<0.05) using the latest Genespring GX11 (Agilent, 
USA). The statistically significant gene list result was filtered based on the 
standard 2 Fold cut-off compared with the Day 0 expression values. The 
differentially expressed genes were then classified and clustered based on the 
Database for Annotation, Visualization, and Integrated Discovery (DAVID) 
Analysis  [8, 9]. Furthermore, the differentially expressed pathways were 
visualized through KEGG pathway interaction maps [10 - 12].  
 
Results: 
The Dextran Sulphate Sodium (DSS) induced acute and chronic colitis models 
are often performed in experimental animals, especially in the most susceptible 
strains of mice, such as C57BL/6j to mimic the ulcerative colitis (UC) in 
humans. Fang et al. (2011) have recently performed a high throughput 
genomics study by administering 3% Dextran Sulphate Sodium (DSS) in the 
drinking water to C57BL/6j mice and collected the colonic tissues from 
individual cohorts at days 0, 2, 4 and 6 for total RNA extraction and detected 
the differential gene expression patterns using Affymerix GeneChip Mouse 
Genome 430 2.0 Array [13]. We have obtained the raw CEL files deposited 
into the Gene Expression Omnibus (GSE22307) to further decipher the key 
genes implicated in the positive regulation of acute inflammation, leukocyte 
adhesion, and neutrophil chemotaxis across in acute DSS colitis. 
 
 
Figure 3: Genespring GX11 analysis of Affymetrix Gene-Chip Expression 
Data from the colonic epithelium of 3% DSS-induced Colitis on Day 0, 2, 4, 
and 6 respectively in C57BL/6j mice. The raw Affymetrix CEL files 
downloaded from Gene Expression Omnibus (GSE22307) were normalized 
with RMA algorithm and subjected to One Way ANOVA, Tukey HSD and 
Bonferroni FDR(p<0.05).  The resulting gene list was filtered based on 2 Fold 
cut-off compared with the Day 0 expression values. The differentially 
expressed genes were then classified and clustered based on Gene Ontology 
(GO) Analysis to decipher the differentially expressed genes in (A) Positive 
Regulation of Acute Inflammation, (B) Chemotaxis, (C) Leukocyte Adhesion, 
(D) Neutrophil Chemotaxis, and (E) Leukocyte Activation. 
 
The induction of acute inflammation by the oral administration of DSS causes 
the expression of various proinflammatory genes in the colonic epithelium. 
Specific focus into the expression of adhesion molecules as well as the genes 
implicated in the chemotaxis of leukocytes such as the neutrophils through the 
Gene Ontology Analysis module in Genespring GX11, have revealed the 
differential expression of key genes which positively regulate the acute 
inflammation such as IL-1ß, IL-6, CCL5, CCR5, FcgRI, FcgRIII, FceRIg, and 
PTGS2, were significantly up-regulated at least 2 fold in the log scale by the 
acute inflammation triggered by DSS in the colonic tissue (Figure 3A). A 
plethora of genes positively influencing the leukocyte chemotaxis such as 
CCL2, CCL7, CCL8, CCL5, IL-1 beta, CXCL1, CXCL2, CXCL3,  etc., were 
significantly up-regulated by the acute inflammation triggered by DSS (Figure 
3B). In addition, the adhesion molecules such as ICAM1, VCAM1, ITGAM, 
ITGAL, and P-Selectin, were up-regulated (at least 2 Fold) (Figure 3C). These 
adhesion molecules play a key role in the adhesion and transmigration of 
neutrophils across colonic epithelium as well as vascular endothelium to the 
site of infection or inflammation. Furthermore, the genes specifically BIOINFORMATION  open access 
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influencing neutrophil chemotaxis such as CXCL1, CXCL2, CXCL3, CCL2, 
CCL2, C5aR1, ITGAM, ITGB2 etc., were significantly up-regulated by the 
acute inflammation triggered by DSS (Figure 3D). In addition, the leukocyte 
activating genes such as CD86, HDAC9, Fc Receptors, Dock2, LCP2 etc. were 
also up-regulated in this model (Figure 3E). In order to decipher the cellular 
and molecular processes induced to cause the leukocyte transendothelial 
migration across the blood vessels, we have performed the DAVID analysis of 
the differentially expressed genes. Furthermore, we obtained the KEGG 
pathways for the leukocyte transendothelial migration (Figure 4) as well as 
Chemokine Signaling (Figure 5) and identified the differentially expressed 
genes from our gene list in the Canonical Pathway to decipher the key 
chemokines as well as cytokines implicated in the leukocyte transendothelial 
migration induced by DSS. 
 
 
Figure 4: Leukocyte Transendothelial Migration Pathway. KEGG Pathway 
Analysis of Genes Implicated in the Leukocyte Transendothelial Migration 




Figure 5: Chemokine Signaling Pathway. KEGG Pathway Analysis of Genes 
Implicated in the Chemokine Signaling (Red Stars) in the colonic epithelial 
tissue of 3% DSS-induced Colitis in C57BL/6j mice. 
 
Discussion: 
Several classes of adhesion molecules mediate neutrophil attachment to 
endothelial cells during acute inflammatory state, including selectins, which 
bind to their carbohydrate-based ligands, and integrins, which in turn bind to 
CAMs [2]. The initial tethering event is initiated through selectins, and the later 
development of tight adhesion is proposed to exploit α4β1 (VLA-4)–VCAM 
(vascular CAM interactions, followed by αL/Mβ2 (LFA-1/Mac-1)–ICAM 
(intercellular CAM) adhesion [7]. The selectins include a group of three related 
molecules. L-selectin is constitutively expressed on neutrophils and is shed 
from the cell surface on cell activation, assumed to occur immediately after 
rolling begins. P-selectin is found on platelets and is stored in Weibel-Palade 
bodies where it is rapidly (within few minutes) transported to the cell surface 
after endothelial cell activation by stimuli such as histamine, thrombin, 
bradykinin, leukotriene C4 (LTC4), or free radicals. E-selectin (ELAM-1) is 
expressed solely on endothelial cells where it is synthesized rapidly after cell 
stimulation by cytokines (TNF-α, IL-1) or endotoxin and then translocated to 
the luminal surface of the venular endothelium. Each selectin shares a common 
molecular structure, most notably an NH2-terminal lectin-like domain, which 
imparts the ability of each selectin to bind to specific carbohydrate ligands [14, 
15]. In addition, during the primary phase of acute inflammation, the initial 
selectin-based adhesive events stimulate sequential activation of downstream 
adhesion receptors [14, 15].  Involvement of neutrophil L-selectin increases the 
adhesiveness of β2 integrins for ICAM [14-17]. Further analysis shows that L-
selectin cross-linking induces firm adhesion of neutrophils under flow 
conditions, accompanied by increases in actin polymerization and 
colocalization of β2 integrins with L-selectin [16]. Engagement of L-selectin 
induces calcium release, MAP kinases, tyrosine kinases and small G-protein 
signaling in the neutrophils that may influence β2 integrin adhesiveness [18-
20]. It was reported that p38MAPK inhibitors block L-selectin-induced 
changes to both neutrophil shape and β2- mediated adhesion. Hence, selectins 
play an important role in initiating the sequential adhesion cascade through 
both adhesive and signaling events in the neutrophils [21]. 
 
For neutrophils, tight adhesion needs activation of the β2-integrin family 
(CD18), resulting in binding to one of the intercellular adhesion molecules on 
the surfaces of endothelial cells. The CD11/CD18 integrins, such as Mac-1 and 
LFA-1, interact with the immunoglobulin superfamily member and ICAM-1. 
The CD 11b is capable of binding a wide range of ligands on endothelial cells 
[15, 16, 19, 20]. An important characteristic of the neutrophil integrins is that 
under baseline conditions they exist in a relatively inactive conformation, 
rendering the leukocyte non-adhesive. One of the key events of the adhesion 
cascade is the activation (occasionally accompanied by the inclusion of a 
protein on the cell surface) and deactivation of these integrins at the proper 
times and places. Integrin-mediated adhesion is regulated by modulating either 
the affinity of the integrin for its ligand or by altering the avidity of adhesion 
through integrin clustering and cell spreading phenomenon. The coordination 
of adhesion by integrin molecules is mediated by two types of signaling events 
which are particularly appropriate for transendothelial migration of leukocytes, 
namely, cross-talk between CAMs and stimulation by chemokines through 
chemokine receptors on neutrophils [15, 16, 19, 20]. 
 
The diapedesis or transmigration of neutrophils across an endothelial 
monolayer requires a chemotactic gradient [21].The cytokines, such as TNF-α 
and IL-1, cause expression of potent chemotactic stimuli such as IL-8, which 
affect both adherence and transmigration of neutrophils [23]. The platelet-
endothelial cell adhesion molecule-1 (PECAM-1), a member of the 
immunoglobulin super family, is expressed at relatively low levels on the 
surface of leukocytes and platelets but at higher levels (>106molecules per cell) 
on endothelium.  PECAM-1 plays a key role in transmigration of neutrophils 
across the endothelium [6, 7].  Its localization at the junctions between 
endothelial cells has suggested a role in transendothelial cell migration. Using 
an in vitro model, Muller et al. (1993) demonstrated that antibodies against 
PECAM-1 significantly blocked leukocyte transmigration through TNF-α 
activated endothelial cell monolayers but did not affect the adhesion of 
neutrophils [24]. This effect has been confirmed earlier in animal models of 
neutrophil transmigration [6]. The mechanisms by which PECAM-1 may 
regulate transendothelial migration are not yet known; however, the 
possibilities include direct binding of PECAM-I to the leukocyte (perhaps 
serving as a molecular guide as it passes through the junction), or regulation of 
adhesion molecules on the surface of the leukocyte (i.e., β2 integrins), thus 
facilitating transmigration [24]. Available data indicate that cross-linking of 
PECAM-1 on the surface of leukocytes by antibodies can up-regulate integrin-
mediated binding [25].  Another process that may play an important role in 
transendothelial migration is the ability of the endothelial cell monolayer to 
regulate an opening of its junctions, allowing neutrophil transmigration. Recent 
work by Huang et al. suggests that transmigrating neutrophils (in response to a 
chemotactic stimulus) exert an active influence on the endothelial cell BIOINFORMATION  open access 
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monolayer, resulting in increased intracellular endothelial calcium levels and 
opening of intercellular junctions [26]. 
 
Role of Chemokines and Cytokines in Neutrophil Transmigration: 
Several chemokines regulate the order and timing of integrin adhesions [23], 
and several chemokines upregulate β2-mediated adhesions of neutrophils [27]. 
More recently, a role for specific chemokines in distinct steps of neutrophil 
extravasation has been described [7, 23]. These studies show that the 
chemokines GROα and fractalkine mediate the initial firm adhesion, whereas 
the chemokine MCP-1 is required for the later steps of neutrophil spreading 
and diapedesis [23]. The chemokines play a key role in directing the multi-step 
model of extravasation by promoting the appropriate sequence of integrin 
activation/ inactivation and the associated cell behavior. Migration of 
neutrophils is the result of choreographed changes in both cell morphology and 
adhesion. Membrane protrusions and the formation of new adhesive contacts at 
the leading edge of a migrating cell must be coordinated with down-regulation 
of adhesion and retraction at the rear of the cell [28]. PAF is synthesized by 
endothelial cells within minutes after stimulation by thrombin, histamine, 
LTC4, or other agonists, and is expressed on the cell surface where it activates 
neutrophils and up-regulates CD 11b by binding to a specific cell-surface 
receptor [29]. Many of the same factors that stimulate PAF expression also 
cause rapid translocation of P-selectin to the surface of the endothelium. Thus, 
for at least one set of stimuli both a specific tethering molecule (P-selectin) and 
a specific activator molecule (PAF) are produced. A similar situation may exist 
for the neutrophil chemoattractant/activator IL-8, which appears to bind to the 
luminal surface of activated endothelial cells where it is able to activate 
neutrophils [29]. Since cytokines, such as TNFα, and other factors (such as 
endotoxin) cause the synthesis of both IL-8 and E-selectin from endothelial 
cells  [30], it is likely that these mediators may augment neutrophil 
transmigration by stimulating expression of both the tethering molecule and the 
activating factor [31]. Important ligands for the CD11/CD18 integrins are 
ICAM-1, and possibly ICAM-2 [2, 3]. These molecules, members of the 
immunoglobulin superfamily, are present constitutively on endothelial cells 
both  in vitro and  in vivo. CD11a and CDI1b bind to ICAM-1 in different 
regions of the molecule. Only CD 11a has been shown to be capable of binding 
to ICAM-2. The cytokines such as TNF-α and IL-1 cause expression of potent 
chemotactic stimuli such as IL-8 [31, 32], which affect both adherence and 
transmigration of neutrophils. 
 
Conclusions and Future Directions: 
Leukocytes such as neutrophils undergo dynamic changes in cell-shape and 
adhesive properties during transmigration through endothelium of blood 
vessels in response to inflammatory signals. In this article, we have addressed 
the dynamics of CAMs and chemokine interactions in mediating this 
extravasation. Moreover, we discussed the key molecular events which lie 
beneath these key steps of neutrophil transmigration in acute inflammation 
induced by DSS in the colon of mice. In future, the evolution of State of the Art 
cellular and molecular imaging techniques in vitro and in vivo will definitely 
offer a finer resolution of the spatio-temporal regulation of key CAMs and 
chemokines to decipher the complete picture of how the activities of individual 
molecules are orchestrated during neutrophil transmigration in acute 
inflammatory diseases. This knowledge is pivotal for specifically 
targeting/designing personalized medicines/therapeutics [33-36] to ameliorate 
various inflammatory diseases, such as rheumatoid arthritis, asthma, 
anaphylaxis, atherosclerosis, ulcerative colitis etc., in the near future.  
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